May 13, 2020

Two More FDA-Approved Drugs Are Promising for COVID-19 Treatment

Research on possible new treatments for COVID-19 seem to be going on everywhere. It is important for pharmacists to keep up because drugs identified as promising can suddenly be in short supply almost overnight. Here is information about two FDA-approved drugs that are undergoing scrutiny now.                                    


‘Deaths of Despair’ Lower in Pharmacists, Other Providers With Religious Activity

Even before the current COVID-19 pandemic, the United States was facing a public health crisis with deaths of despair, i.e., those involving drugs, alcohol, and suicide. Noting that healthcare professionals, including pharmacists, aren’t exempt, a recent study looked at whether religious involvement provided any protection. Here are more details. 

Atrial Fibrillation Risk Can Be Reduced by Intensive Blood Pressure Control

Lowering systolic blood pressure (BP) to less than 120 has a benefit beyond just hypertension control. Find out how much intensive BP control can lower the risk of atrial fibrillation, according to a new study using data from the SPRINT trial. 


Newer Flu Vaccines Shown Safe, Effective Postmarket in
Older Recipients

Pharmacists have a growing arsenal of influenza vaccines to help protect people, especially older adults, against the seasonal scourge. But how safe are the newer vaccines? Find out the answer from an Australian study that assessed their postmarketing safety profile, including the enhanced trivalent inactivated influenza vaccines.                       

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -